These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7271873)

  • 41. Melanosome binding and oxidation-reduction properties of synthetic L-dopa-melanin as in vitro tests for drug toxicity.
    Debing I; Ijzerman AP; Vauquelin G
    Mol Pharmacol; 1988 Apr; 33(4):470-6. PubMed ID: 3357487
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding of chemicals to melanins re-examined: adsorption of some drugs to the surface of melanin particles.
    Bridelli MG; Ciati A; Crippa PR
    Biophys Chem; 2006 Jan; 119(2):137-45. PubMed ID: 16139945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radiosensitization of malignant melanoma--I. The effect of 7-hydroxy-chlorpromazine on the in vivo radiation response of Fortner's melanoma.
    Damsker JI; Macklis R; Brady LW
    Int J Radiat Oncol Biol Phys; 1978; 4(9-10):821-4. PubMed ID: 711551
    [No Abstract]   [Full Text] [Related]  

  • 44. 3H-azidopine photoaffinity labeling of high molecular weight proteins in chloroquine resistant falciparum malaria.
    Ye ZG; Van Dyke K; Spearman T; Safa AR
    Biochem Biophys Res Commun; 1989 Jul; 162(2):809-13. PubMed ID: 2667521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Accumulation in vitro of 35 S-chlorpromazine in the neuromelanin of human substantia nigra and locus coeruleus.
    Lindquist NG
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):190-5. PubMed ID: 4643285
    [No Abstract]   [Full Text] [Related]  

  • 46. Interaction of chlorpromazine, fluphenazine and trifluoperazine with ocular and synthetic melanin in vitro.
    Buszman E; Beberok A; Rózańska R; Orzechowska A
    Pharmazie; 2008 May; 63(5):372-6. PubMed ID: 18557422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. On the binding of the bisquaternary ammonium compound paraquat to melanin and cartilage in vivo.
    Larsson B; Oskarsson A; Tjälve H
    Biochem Pharmacol; 1978; 27(13):1721-4. PubMed ID: 708451
    [No Abstract]   [Full Text] [Related]  

  • 48. Binding of drugs to eye melanin is not predictive of ocular toxicity.
    Leblanc B; Jezequel S; Davies T; Hanton G; Taradach C
    Regul Toxicol Pharmacol; 1998 Oct; 28(2):124-32. PubMed ID: 9927562
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on the melanin affinity of selegiline (deprenyl) and other amphetamine derivatives.
    Báthory G; Szüts T; Magyar K
    Pol J Pharmacol Pharm; 1987; 39(2):195-201. PubMed ID: 3124086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A qualitative study of the melanins from blue and brown human eyes.
    Menon IA; Persad S; Haberman HF; Kurian CJ; Basu PK
    Exp Eye Res; 1982 Apr; 34(4):531-7. PubMed ID: 7075710
    [No Abstract]   [Full Text] [Related]  

  • 51. Physical factors affecting chloroquine binding to melanin.
    Schroeder RL; Pendleton P; Gerber JP
    Colloids Surf B Biointerfaces; 2015 Oct; 134():8-16. PubMed ID: 26141438
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The binding properties of melanin: in vivo and in vitro.
    Blois MS
    Adv Biol Skin; 1972; 12():65-79. PubMed ID: 4579208
    [No Abstract]   [Full Text] [Related]  

  • 53. Distribution and metabolism of doxepin.
    Hobbs DC
    Biochem Pharmacol; 1969 Aug; 18(8):1941-54. PubMed ID: 5811627
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of various drugs on longevity in female C57BL-6J mice.
    Hochschild R
    Gerontologia; 1973; 19(5):271-80. PubMed ID: 4788962
    [No Abstract]   [Full Text] [Related]  

  • 55. Affinity of labetalol for ocular melanin.
    Poynter D; Martin LE; Harrison C; Cook J
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):711-20. PubMed ID: 990153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Types of interaction of amphiphilic drugs with phospholipid vesicles.
    Joshi UM; Kodavanti PR; Coudert B; Dwyer TM; Mehendale HM
    J Pharmacol Exp Ther; 1988 Jul; 246(1):150-7. PubMed ID: 3392651
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retention of the cyanobacterial neurotoxin beta-N-methylamino-l-alanine in melanin and neuromelanin-containing cells--a possible link between Parkinson-dementia complex and pigmentary retinopathy.
    Karlsson O; Berg C; Brittebo EB; Lindquist NG
    Pigment Cell Melanoma Res; 2009 Feb; 22(1):120-30. PubMed ID: 19154235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The melanin binding of drugs and its implications.
    Ings RM
    Drug Metab Rev; 1984; 15(5-6):1183-212. PubMed ID: 6396056
    [No Abstract]   [Full Text] [Related]  

  • 59. Reversible, light-screening pigment of elasmobranch eyes: chemical identity with melanin.
    Fox DL; Kuchnow KP
    Science; 1965 Oct; 150(3696):612-4. PubMed ID: 5837098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro melanin binding of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist.
    Yamada T; Okuyama Y; Mukai H
    Arzneimittelforschung; 2001; 51(4):299-303. PubMed ID: 11367870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.